tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
RenovoRx Reports Strong Q2 2025 Revenue Growth
PremiumCompany AnnouncementsRenovoRx Reports Strong Q2 2025 Revenue Growth
26d ago
Meet RenovoRx: Fly exclusive interview with CEO Shaun Bagai
Premium
The Fly
Meet RenovoRx: Fly exclusive interview with CEO Shaun Bagai
1M ago
Phase 3 TIGeR-PaC Trial progressing well, RenovoRx CEO says
Premium
The Fly
Phase 3 TIGeR-PaC Trial progressing well, RenovoRx CEO says
1M ago
RenovoRx price target raised to $11.50 from $11 at Ascendiant
PremiumThe FlyRenovoRx price target raised to $11.50 from $11 at Ascendiant
3M ago
RenovoRx Buy Rating: Promising RenovoCath Adoption and TIGeR-PaC Study Progress Drive Positive Outlook
Premium
Ratings
RenovoRx Buy Rating: Promising RenovoCath Adoption and TIGeR-PaC Study Progress Drive Positive Outlook
4M ago
RenovoRx’s Innovative Drug Delivery and Promising Clinical Trials Earn a Buy Rating
Premium
Ratings
RenovoRx’s Innovative Drug Delivery and Promising Clinical Trials Earn a Buy Rating
4M ago
RenovoRx announces Johns Hopkins initiated for TIGeR-PaC Phase 3 trial
PremiumThe FlyRenovoRx announces Johns Hopkins initiated for TIGeR-PaC Phase 3 trial
4M ago
RenovoRx Reports Initial Revenue and Clinical Trial Progress
Premium
Company Announcements
RenovoRx Reports Initial Revenue and Clinical Trial Progress
5M ago
RenovoRx increases production of RenovoCath
Premium
The Fly
RenovoRx increases production of RenovoCath
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100